Kamau uses ex vivo homology-directed repair to write therapeutic DNA sequences into autologous hematopoietic stem cells
Kamau uses ex vivo homology-directed repair to write therapeutic DNA sequences into autologous hematopoietic stem cells. This precision creates a foundation for medicines designed to deliver lasting benefit from a single intervention.